癌症家族史可独立于林奇综合征预测子宫内膜癌风险:对遗传咨询的启示
本研究基于1353例子宫内膜癌患者和628名对照,分析自报癌症家族史与子宫内膜癌风险的关联。结果显示,一级或二级亲属中有子宫内膜癌者风险显著升高(P=3.8×10-7),且与亲属关系更近、亲属诊断年龄更轻及亲属中林奇癌数量增多呈趋势相关。该关联与患者肿瘤错配修复状态和组织学亚型无关,提示林奇综合征基因不能完全解释家族性子宫内膜癌风险。
要点
- 一级或二级亲属有子宫内膜癌与子宫内膜癌风险显著升高相关(P=3.8×10-7)。
- 亲属关系越近、亲属诊断子宫内膜癌年龄越轻,风险越高(趋势P=4.43×10-6)。
- 亲属中林奇癌数量越多,风险越高(趋势P≤0.0001),且关联与错配修复状态无关。
核心结论
- 子宫内膜癌风险最强的预测因素是一级或二级亲属中至少1人患子宫内膜癌且关系更近、诊断年龄更轻。
- 该关联与患者肿瘤错配修复状态和组织学亚型无关,排除错配修复致病性变异携带者后仍显著,提示林奇综合征基因不能完全解释家族性子宫内膜癌风险。
研究设计与样本
- 研究纳入1353例子宫内膜癌患者和628名对照,使用自报癌症家族史。
- 采用逻辑回归量化至少1名一级或二级亲属患癌与子宫内膜癌的关联,并评估亲属关系程度和亲属诊断年龄的影响。
- 对678例患者的子集评估子宫内膜癌肿瘤错配修复基因表达。
主要发现
- 至少1名一级或二级亲属报告子宫内膜癌与子宫内膜癌风险显著升高相关(P=3.8×10-7),独立于生活方式危险因素。
- 子宫内膜癌风险随亲属关系更近和亲属诊断子宫内膜癌年龄更轻呈趋势升高(趋势P=4.43×10-6)。
- 子宫内膜癌风险随亲属中林奇癌数量增多呈趋势升高(趋势P≤0.0001)。
- 家族史相关的子宫内膜癌风险在患者肿瘤错配修复状态或组织学亚型间无差异。
- 对潜在错误报告家族史进行保守校正后,一级或二级亲属报告子宫内膜癌仍与子宫内膜癌风险相关(OR 2.0;95%CI 1.24-3.37,P=0.004)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine endometrial cancer (EC) risk according to family cancer history, including assessment by degree of relatedness, type of and age at cancer diagnosis of relatives. METHODS: Self-reported family cancer history was available for 1353 EC patients and 628 controls. Logistic regression was used to quantify the association between EC and cancer diagnosis in ≥1 first or second degree relative, and to assess whether level of risk differed by degree of relationship and/or relative's age at diagnosis. Risk was also evaluated for family history of up to three cancers from known familial syndromes (Lynch, Cowden, hereditary breast and ovarian cancer) overall, by histological subtype and, for a subset of 678 patients, by EC tumor mismatch repair (MMR) gene expression. RESULTS: Report of EC in ≥1 first- or second-degree relative was associated with significantly increased risk of EC (P=3.8×10-7), independent of lifestyle risk factors. There was a trend in increasing EC risk with closer relatedness and younger age at EC diagnosis in relatives (PTrend=4.43×10-6), and with increasing numbers of Lynch cancers in relatives (PTrend≤0.0001). EC risk associated with family history did not differ by proband tumor MMR status, or histological subtype. Reported EC in first- or second-degree relatives remained associated with EC risk after conservative correction for potential misreported family history (OR 2.0; 95% CI, 1.24-3.37, P=0.004). CONCLUSION: The strongest predictor of EC risk was closer relatedness and younger EC diagnosis age in ≥1 relative. Associations remained significant irrespective of proband MMR status, and after excluding MMR pathogenic variant carriers, indicating that Lynch syndrome genes do not fully explain familial EC risk.
引用
- Johnatty SE, Tan YY, Buchanan DD, et al. Family history of cancer predicts endometrial cancer risk independently of Lynch Syndrome: Implications for genetic counselling. Gynecol Oncol. 2017. PMID: 28822557. doi:10.1016/j.ygyno.2017.08.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。